| Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance F Martins, L Sofiya, GP Sykiotis, F Lamine, M Maillard, M Fraga, ... Nature reviews Clinical oncology 16 (9), 563-580, 2019 | 1938 | 2019 |
| Glucocorticoid corticosteroids for Duchenne muscular dystrophy AY Manzur, T Kuntzer, M Pike, AV Swan Cochrane database of systematic reviews, 2008 | 916 | 2008 |
| Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke MAS Trial—Italy The Lancet 346 (8989), 1509-1514, 1995 | 587 | 1995 |
| Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study E Nelis, C Van Broeckhoven, P De Jonghe, A Löfgren, A Vandenberghe, ... European Journal of Human Genetics 4 (1), 25-33, 1996 | 533 | 1996 |
| Corticosteroids for the treatment of Duchenne muscular dystrophy E Matthews, R Brassington, T Kuntzer, F Jichi, AY Manzur Cochrane Database of Systematic Reviews, 2016 | 495 | 2016 |
| Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study T Meier, G Wasner, M Faust, T Kuntzer, F Ochsner, M Hueppe, ... Pain 106 (1-2), 151-158, 2003 | 482 | 2003 |
| A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses IA Gillespie, SJ O’Brien, JA Frost, GK Adak, P Horby, AV Swan, MJ Painter, ... Emerging infectious diseases 8 (9), 937, 2002 | 405 | 2002 |
| Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies I Le Ber, MC Moreira, S Rivaud‐Péchoux, C Chamayou, F Ochsner, ... Brain 126 (12), 2761-2772, 2003 | 277 | 2003 |
| Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies) T Kuntzer, JC Antoine, AJ Steck Muscle & Nerve: Official Journal of the American Association of …, 2004 | 249 | 2004 |
| Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy JM Léger, K Viala, G Nicolas, A Créange, JM Vallat, J Pouget, P Clavelou, ... Neurology 80 (24), 2217-2225, 2013 | 208 | 2013 |
| New therapeutic perspectives to manage refractory immune checkpoint-related toxicities F Martins, GP Sykiotis, M Maillard, M Fraga, C Ribi, T Kuntzer, O Michielin, ... The Lancet Oncology 20 (1), e54-e64, 2019 | 195 | 2019 |
| Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy E Scott, M Eagle, A Mayhew, J Freeman, M Main, J Sheehan, A Manzur, ... Physiotherapy Research International 17 (2), 101-109, 2012 | 191 | 2012 |
| Acetylcholinesterase inhibitor treatment for myasthenia gravis MM Mehndiratta, S Pandey, T Kuntzer Cochrane Database of Systematic Reviews, 2014 | 183 | 2014 |
| The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials V Ricotti, DA Ridout, M Pane, M Main, A Mayhew, E Mercuri, AY Manzur, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 149-155, 2016 | 182 | 2016 |
| Organization of stroke care: education, stroke units and rehabilitation M Kaste, T Skyhoj Olsen, JM Orgogozo, J Bogousslavsky, W Hacke Cerebrovascular diseases 10 (Suppl. 3), 1-11, 2000 | 162 | 2000 |
| Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene MR Davis, E Haan, H Jungbluth, C Sewry, K North, F Muntoni, T Kuntzer, ... Neuromuscular disorders 13 (2), 151-157, 2003 | 156 | 2003 |
| Early onset collagen VI myopathies: Genetic and clinical correlations L Briñas, P Richard, S Quijano‐Roy, C Gartioux, C Ledeuil, E Lacène, ... Annals of neurology 68 (4), 511-520, 2010 | 152 | 2010 |
| European stroke initiative (EUSI) recommendations for stroke management the European stroke initiative writing committee W Hacke, M Kaste, T Skyhoj Olsen, JM Orgogozo, J Bogousslavsky European journal of neurology 7 (6), 607-623, 2000 | 150 | 2000 |
| Carpal tunnel syndrome in 100 patients: sensitivity, specificity of multi-neurophysiological procedures and estimation of axonal loss of motor, sensory and sympathetic median … T Kuntzer Journal of the neurological sciences 127 (2), 221-229, 1994 | 150 | 1994 |
| Exercise test in muscle channelopathies and other muscle disorders T Kuntzer, F Flocard, C Vial, A Kohler, MR Magistris, A Labarre‐Vila, ... Muscle & Nerve: Official Journal of the American Association of …, 2000 | 118 | 2000 |
